000			01904 a2200541 4500
005			20250517134352.0
264		0	_c20170724
008			201707s 0 0 eng d
022			_a1532-2777
024	7		_a10.1016/j.mehy.2016.12.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aDamar, Ugur
245	0	0	_aHuperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease. _h[electronic resource]
260			_bMedical hypotheses _cFeb 2017
300			_a57-62 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcetylcholinesterase _xmetabolism
650	0	4	_aAlkaloids _xtherapeutic use
650	0	4	_aAlzheimer Disease _xdrug therapy
650	0	4	_aAmyloid beta-Peptides _xmetabolism
650	0	4	_aAnimals
650	0	4	_aAnimals, Genetically Modified
650	0	4	_aAnticonvulsants _xtherapeutic use
650	0	4	_aCholinesterase Inhibitors _xtherapeutic use
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aEpilepsy _xdrug therapy
650	0	4	_aGABAergic Neurons _xmetabolism
650	0	4	_aHippocampus _xmetabolism
650	0	4	_aHumans
650	0	4	_aInterleukin-1beta _xmetabolism
650	0	4	_aMemory _xdrug effects
650	0	4	_aNeurons _xmetabolism
650	0	4	_aNeuroprotective Agents _xtherapeutic use
650	0	4	_aPhosphorylation
650	0	4	_aRisk
650	0	4	_aRisk Factors
650	0	4	_aSeizures
650	0	4	_aSesquiterpenes _xtherapeutic use
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
700	1		_aGersner, Roman
700	1		_aJohnstone, Joshua T
700	1		_aSchachter, Steven
700	1		_aRotenberg, Alexander
773	0		_tMedical hypotheses _gvol. 99 _gp. 57-62
856	4	0	_uhttps://doi.org/10.1016/j.mehy.2016.12.006 _zAvailable from publisher's website
999			_c26806889 _d26806889